Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Noncurrent accrued rebates & revenue deductions by Quarter
Noncurrent accrued rebates & revenue deductions (Other noncurrent liabilities) ($M) ($M)
Pfizer Noncurrent accrued rebates & revenue deductions: $332M in Q2 2026, down 55.3% from a year earlier.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Note 17 — Revenue Deductions & Rebate Accruals.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Noncurrent accrued rebates & revenue deductions (Other noncurrent liabilities) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 332 | -55.3% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 287 | -37.7% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 1,204 | +17.0% | Form 10-Q (filed 2026-08-04) ↗ |
| Q3 2025 | Sep 28, 2025 | 1,009 | +22.7% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | 742 | +30.4% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 30, 2025 | 461 | +20.7% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 1,029 | +29.3% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | 822 | +28.4% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 569 | +20.3% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 382 | +17.9% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 796 | +30.1% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2023 | Oct 1, 2023 | 640 | – | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2023 | Jul 2, 2023 | 473 | – | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2023 | Apr 2, 2023 | 324 | – | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 612 | +41.3% | Form 10-K (filed 2024-02-22) ↗ |
| Q4 2021 | Dec 31, 2021 | 433 | +8.5% | Form 10-K (filed 2023-02-23) ↗ |
| Q4 2020 | Dec 31, 2020 | 399 | +3.9% | Form 10-K (filed 2022-02-24) ↗ |
| Q4 2019 | Dec 31, 2019 | 384 | – | Form 10-K (filed 2021-02-25) ↗ |
Cite this data
StockData. (2026). Pfizer Noncurrent accrued rebates & revenue deductions ($M), quarterly Q4 2019–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/gtn-noncur
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.